Author:
Araujo da Silva André Ricardo,Marques Amanda,Di Biase Clara,Faitanin Monique,Murni Indah,Dramowski Angela,Hübner Johannes,Zingg Walter
Abstract
IntroductionAntimicrobial stewardship programmes (ASPs) are recommended to improve antibiotic use in healthcare and reduce antimicrobial resistance (AMR). Our aim was to investigate the effectiveness of ASPs in reducing antibiotic consumption, use of broad-spectrum/restricted antibiotics, antibiotic resistance and healthcare-associated infections (HAIs) in neonates.MethodsWe searched PUBMED, SCIELO, EMBASE and the Cochrane Database (January 2000–April 2019) to identify studies on the effectiveness of ASPs in neonatal wards and/or neonatal intensive care units (NICUs). Outcomes were as follows: reduction of antibiotic consumption overall and of broad-spectrum/target antibiotics, inappropriate antibiotic use, antibiotic resistance and HAIs. ASPs conducted in settings other than acute care hospitals, for children older than 1 month, and ASPs addressing antifungal and antiviral agents, were excluded.ResultsThe initial search identified 53 173 titles and abstracts; following the application of filters and inclusion criteria, a total of six publications were included in the final analysis. All studies, of which one was multi-centre study, were published after 2010. Five studies were conducted exclusively in NICUs. Four articles applied multimodal interventions. Reduction of antibiotic consumption overall and/or inappropriate antibiotic use were reported by four articles; reduction of broad-spectrum/targeted antibiotics were reported by four studies; No article evaluated the impact of ASPs on AMR or the incidence of HAI in neonates.ConclusionASPs can be effectively applied in neonatal settings. Limiting the use of broad-spectrum antibiotics and shorting the duration of antibiotic treatment are the most promising approaches. The impact of ASPs on AMR and HAI needs to be evaluated in long-term studies.
Subject
Pediatrics, Perinatology, and Child Health
Reference45 articles.
1. Abraham EP , Chain E . An enzyme from bacteria able to destroy penicillin. Nature 1940;146:837.doi:10.1038/146837a0
2. Penicillin’s Discovery and Antibiotic Resistance: Lessons for the Future?;Lobanovska;Yale J Bio Med,2017
3. Paediatric drug use with focus on off-label prescriptions in Lombardy and implications for therapeutic approaches
4. Center for Drug Evaluation and Research . 2018 new drugs therapy approval. USA, 2018. Available: https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2018 [Accessed 01 Jul 2019].
5. Antibiotic Use in Children - Off-Label Use
Cited by
30 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献